Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients

Table 2 Comparison of the different studied groups with regard to alpha-fetoprotein and annexin A2¹

Parameter	HCC vs control		CLD vs control		HCC vs CLD
	Z value	P value	Z value	P value	Z value	P value
AFP (ng/mL)	-5.006	< 0.012	-3.4	< 0.012	-4.17	< 0.012
ANXA2 (ng/mL)	-3.5	< 0.012	-1.6	> 0.05	-4.8	< 0.012

¹Wilcoxon Rank Sum test (non-parametric data);

²Statistically significant difference. AFP: Alpha-fetoprotein; ANXA2: Annexin A2; HCC: Hepatocellular carcinoma; CLD: Chronic liver disease.